Jillian Brown

Dr. Brown is the Director of Research and Development at TEGA Therapeutics. As the Director, she leads the MPS Program developing enzyme replacement therapies for the treatment of lysosomal storage disorders. Previously, she was a Senior Scientist at BioMarin Pharmaceuticals Inc. and the Biology leader of a small molecule drug discovery program. Prior to that, she was a Group leader at Zacharon Pharmaceuticals Inc. She is an inventor on several patents filed covering intellectual property in the area of Glycobiology research and the Principal Investigator on several NIH funded grants.

Dr. Brown earned her B.S in Chemistry from the University of Dundee, Scotland. She earned her Ph.D. in Biological Chemistry from the University of Dundee and the University of St Andrews, Scotland. She completed her postdoctoral studies in Biomedical Sciences at the Glycobiology Research and Training Center at the University of California, San Diego.